BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33858297)

  • 1. circ-PSD3 promoted proliferation and invasion of papillary thyroid cancer cells via regulating the miR-7-5p/METTL7B axis.
    Zhu J; Wang Y; Yang C; Feng Z; Huang Y; Liu P; Chen F; Deng Z
    J Recept Signal Transduct Res; 2022 Jun; 42(3):251-260. PubMed ID: 33858297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circ_PSD3 promotes the progression of papillary thyroid carcinoma via the miR-637/HEMGN axis.
    Li Z; Huang X; Liu A; Xu J; Lai J; Guan H; Ma J
    Life Sci; 2021 Jan; 264():118622. PubMed ID: 33203523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of circPUM1 impedes cell growth, metastasis and glycolysis of papillary thyroid cancer via enhancing MAPK1 expression by serving as the sponge of miR-21-5p.
    Li Y; Qin J; He Z; Cui G; Zhang K; Wu B
    Genes Genomics; 2021 Feb; 43(2):141-150. PubMed ID: 33481227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The circ_FAM53B-miR-183-5p-CCDC6 axis modulates the malignant behaviors of papillary thyroid carcinoma cells.
    Zhang C; Gu H; Liu D; Tong F; Wei H; Zhou D; Fang J; Dai X; Tian H
    Mol Cell Biochem; 2022 Nov; 477(11):2627-2641. PubMed ID: 35598218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing circRNA protein kinase C iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI/miR-335/E2F3 ceRNA axis.
    Liu Y; Chen G; Wang B; Wu H; Zhang Y; Ye H
    Endocr J; 2021 Jun; 68(6):713-727. PubMed ID: 33716239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ_0079558 promotes papillary thyroid cancer progression by binding to miR-26b-5p to activate MET/AKT signaling.
    Zheng H; Fu Q; Ma K; Shi S; Fu Y
    Endocr J; 2021 Nov; 68(11):1247-1266. PubMed ID: 34565758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_0011058 facilitates proliferation, angiogenesis and radioresistance in papillary thyroid cancer cells by positively regulating YAP1 via acting as miR-335-5p sponge.
    Zhang Z; Wang W; Su Z; Zhang J; Cao H
    Cell Signal; 2021 Dec; 88():110155. PubMed ID: 34562605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA coiled-coil domain containing 66 regulates malignant development of papillary thyroid carcinoma by upregulating La ribonucleoprotein 1
    Li P; Chen J; Zou J; Zhu W; Zang Y; Li H
    Bioengineered; 2022 Mar; 13(3):7181-7196. PubMed ID: 35264065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal circular RNA hsa_circ_007293 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through regulation of the microRNA-653-5p/paired box 6 axis.
    Lin Q; Qi Q; Hou S; Chen Z; Jiang N; Zhang L; Lin C
    Bioengineered; 2021 Dec; 12(2):10136-10149. PubMed ID: 34866540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsa_circ_0058129 regulates papillary thyroid cancer development via miR-873-5p/follistatin-like 1 axis.
    Tan X; Zhao J; Lou J; Zheng W; Wang P
    J Clin Lab Anal; 2022 May; 36(5):e24401. PubMed ID: 35373391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulated hsa_circ_0004458 Contributes to Progression of Papillary Thyroid Carcinoma by Inhibition of miR-885-5p and Activation of RAC1.
    Jin X; Wang Z; Pang W; Zhou J; Liang Y; Yang J; Yang L; Zhang Q
    Med Sci Monit; 2018 Aug; 24():5488-5500. PubMed ID: 30086127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA circ_0008274 enhances the malignant progression of papillary thyroid carcinoma via modulating solute carrier family 7 member 11 by sponging miR-154-3p.
    Ma J; Kan Z
    Endocr J; 2021 May; 68(5):543-552. PubMed ID: 33473055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circ_LDLR promotes the progression of papillary thyroid carcinoma by regulating miR-1294/HMGB3 axis.
    Chen G; Han P; Zhang Q; Li M; Song T; Chen Z; Zhao Y; Yin D; Lv J
    J Biochem Mol Toxicol; 2023 Dec; 37(12):e23498. PubMed ID: 37565296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA hsa_circ_0001666 sponges miR‑330‑5p, miR‑193a‑5p and miR‑326, and promotes papillary thyroid carcinoma progression via upregulation of ETV4.
    Qi Y; He J; Zhang Y; Wang L; Yu Y; Yao B; Tian Z
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33760216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA circBACH2 plays a role in papillary thyroid carcinoma by sponging miR-139-5p and regulating LMO4 expression.
    Cai X; Zhao Z; Dong J; Lv Q; Yun B; Liu J; Shen Y; Kang J; Li J
    Cell Death Dis; 2019 Feb; 10(3):184. PubMed ID: 30796202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circ_0002111/miR-134-5p/FSTL1 signal axis regulates tumor progression and glycolytic metabolism in papillary thyroid carcinoma cells.
    Zhang H; Jiang J; He X; Zhou Q
    J Endocrinol Invest; 2023 Apr; 46(4):713-725. PubMed ID: 36227499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA hsa_circ_0003892 promotes the development of papillary thyroid carcinoma by regulating the miR-326/LASP1 axis.
    Han P; Liu J; Zhao Q; Li H; Zhang T; Li B; Niu X
    Histol Histopathol; 2023 May; 38(5):585-595. PubMed ID: 36394255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Wang D; Zheng Y
    Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA circ_0062389 modulates papillary thyroid carcinoma progression via the miR-1179/high mobility group box 1 axis.
    Wang Y; Zong H; Zhou H
    Bioengineered; 2021 Dec; 12(1):1484-1494. PubMed ID: 33926347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing circ_0000644 inhibits papillary thyroid cancer cell malignancy by combining with miR-671-5p to release the inhibition on ANXA2.
    Li HG; Zhao LH; Liu JZ; Liu KP; Liu JB; Su ZJ; Gao YJ
    J Endocrinol Invest; 2023 Apr; 46(4):749-761. PubMed ID: 36224454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.